REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Teva Baltics (Lithuania)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: UAB Teva Baltics Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Teva Baltics is based in Lithuania, with the head office in Vilnius. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on February 22, 1999. 214 (2025) employees currently work for UAB Teva Baltics. In its most recent financial highlights, the company reported a net sales revenue drop of 3.44% in 2024. In 2024, UAB Teva Baltics’s net profit margin decreased by 8.66%.

Headquarters
Moletu pl. 5
Vilnius; Vilnius county; Postal Code: LT-08411

Contact Details: Purchase the UAB Teva Baltics report to view the information.

Basic Information
Total Employees:
Purchase the UAB Teva Baltics report to view the information.
Registered Capital:
Purchase the UAB Teva Baltics report to view the information.
Financial Auditors:
Purchase the UAB Teva Baltics report to view the information.
Incorporation Date:
February 22, 1999
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Subsidiaries
Uab Teva Baltics Filiale Latvija (Latvia)
Company Performance
Financial values in the chart are available after UAB Teva Baltics report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-3.44%
Total operating revenue
-3.44%
Net Profit (Loss) for the Period
-30.63%
Total Equity
1.87%
Net Profit Margin
-8.66%
Return on Equity (ROE)
-13.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?